Biohaven

Biohaven Biohaven is a uniquely different pharmaceutical company. People are at the center of all we do.

We're an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies.

05/25/2026

Graves’ disease is an autoimmune disorder in which an antibody (TSHR-IgG1) stimulates the thyroid to become overactive. Understanding how it affects the body is the first step toward better care and treatments. Learn more about our work in Graves’: https://bit.ly/4mk5ch4


Our is rooted in purpose and powered by people. We bring passion, collaboration and humility to everything we do becau...
05/22/2026

Our is rooted in purpose and powered by people. We bring passion, collaboration and humility to everything we do because advancing science that changes lives takes more than innovation; it takes intention.

Clinical trials are made possible by dedicated investigators who lead the way in advancing science. Through their work, ...
05/20/2026

Clinical trials are made possible by dedicated investigators who lead the way in advancing science. Through their work, and in partnership with patients who choose to participate, researchers can better understand whether new treatments are safe and effective. This Clinical Trials Day, we recognize the investigators, patients and teams working together to move science forward and bring new possibilities closer to reality.
https://bit.ly/4slfbE0


05/14/2026

Awareness starts with understanding. This , take our “Test Your Knowledge” challenge and learn more about IgA nephropathy (IgAN). Comment your score and visit our website to explore more resources and information: https://bit.ly/4cbeN54


Walking with a purpose! We were honored to join and sponsor the Epilepsy Foundation of Connecticut at the New Haven Walk...
05/12/2026

Walking with a purpose! We were honored to join and sponsor the Epilepsy Foundation of Connecticut at the New Haven Walk for Epilepsy Awareness in support of the millions of people and families impacted by epilepsy. Supporting the epilepsy community is part of our broader commitment to advancing research and exploring potential new therapies for people living with neurological diseases.


Happy Mother’s Day to the mothers on our team and in our lives! Today we’re recognizing the care, strength and dedicatio...
05/10/2026

Happy Mother’s Day to the mothers on our team and in our lives! Today we’re recognizing the care, strength and dedication you bring to your families and to the work you do every day.

Nurses play a critical role in clinical research, working closely with patients, investigators and research teams to hel...
05/06/2026

Nurses play a critical role in clinical research, working closely with patients, investigators and research teams to help ensure clinical trials run safely and effectively. During Nurses Week, we’re recognizing the nurses at clinical trial sites who support patients throughout their trial journey and help advance research that brings new treatments closer. Thank you for all that you do!

This Mental Health Awareness Month, the Biohaven team is thinking of colleagues, friends, and loved ones living with men...
05/05/2026

This Mental Health Awareness Month, the Biohaven team is thinking of colleagues, friends, and loved ones living with mental health challenges. We’re committed to supporting mental well-being through our work and in the way we care for each other every day.


Epilepsy isn’t rare. It impacts millions globally. Awareness brings support, understanding and the ability to advance re...
04/30/2026

Epilepsy isn’t rare. It impacts millions globally. Awareness brings support, understanding and the ability to advance research.
Biohaven’s investigational treatment targets specific potassium channels in the brain, aiming to help people with epilepsy reduce seizures.




IgA Nephropathy (IgAN) doesn’t affect everyone equally. Certain minority populations, particularly Asian/Pacific Islande...
04/23/2026

IgA Nephropathy (IgAN) doesn’t affect everyone equally. Certain minority populations, particularly Asian/Pacific Islander and Hispanic/Latino communities, experience higher incidence, faster disease progression and greater risk of end-stage kidney disease.
Awareness and early detection are key to improving outcomes for these communities. Biohaven is committed to advancing research and developing treatments for IgAN, with a focus on equity, access and patient-centered care.




This World Liver Day, it’s worth remembering that the liver isn’t just vital to metabolism, it’s also one of the body’s ...
04/19/2026

This World Liver Day, it’s worth remembering that the liver isn’t just vital to metabolism, it’s also one of the body’s most powerful natural clearance systems. At Biohaven, our degrader programs are designed to work with the body by leveraging the liver’s inherent ability to remove harmful proteins and antibodies from circulation. By harnessing this natural biology, we aim to pursue more targeted approaches to treating immune-mediated disease.




Address

215 Church Street
New Haven, CT
06510

Website

Alerts

Be the first to know and let us send you an email when Biohaven posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category